| 상품명칭 |
oxymetholone--dea schedule iii |
| 별명 |
Oxymetholone; 17-beta-hydroxy-2-hydroxymethylene-17-alpha-methyl-5-alpha-androstan-3-one; Oxymethenolone; (5alpha,17beta)-17-hydroxy-2-(hydroxymethylidene)-17-methylandrostan-3-one; (2E,5alpha,17beta)-17-hydroxy-2-(hydroxymethylidene)-17-methylandrostan-3-one; (2Z,5alpha,17beta)-17-hydroxy-2-(hydroxymethylidene)-17-methylandrostan-3-one |
| 분자식 |
C21H32O3 |
| 분자량 |
332.477 |
| InChI |
InChI=1/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1 |
| cas번호 |
434-07-1 |
| EC번호 |
207-098-6 |
| 분자 구조 |
|
| 밀도 |
1.169g/cm3 |
| 녹는 점 |
172-180℃ |
| 비등점 |
465.9°C at 760 mmHg |
| 굴절 지수 |
1.589 |
| 인화점 |
249.7°C |
| 물 용해도 |
<0.1 g/100 mL at 23℃ |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
